Key facts
- This page summarizes Manuel Kadre's Form 4 filing for NeueHealth, Inc. (NEUE).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 15 May 2025, 18:34.
Manuel Kadre - 13 May 2025 Form 4 Insider Report for NeueHealth, Inc. (NEUE)
- Reporting relationship
- Director
- Issuer ticker
- NEUE
- Reported as of
- 13 May 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 15 May 2025, 18:34:52 UTC
- Prior SEC filing
- 17 Apr 2025
- Next SEC filing
- 27 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Eric Halverson for Manuel Kadre, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Manuel Kadre filed Form 4 for NeueHealth, Inc. (NEUE) on 15 May 2025.
Change
- Previous filing in this sequence was filed on 17 Apr 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001396538
Primary reporting owner
Kadre Manuel
- Relationship
- Director
- Address
- C/O NEUEHEALTH, INC., 8000 NORMAN CENTER DRIVE, SUITE 900, MINNEAPOLIS
- Signature
- /s/ Eric Halverson for Manuel Kadre, Attorney-in-Fact
- Signature date
- 15 May 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NEUE
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +10,500
- Change %
- +54%
- Price
- $0.000000
- Shares after
- 29,820
- Date
- 13 May 2025
- Ownership
- Direct
NEUE
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,686
- Date
- 13 May 2025
- Ownership
- See note 1.
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NEUE
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -10,500
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 13 May 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,500
- Exercise price
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Reflects securities held by Kadre Family Partnership, L.P., a family limited partnership, of which the Reporting Person is the general partner.
Footnote F2
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Footnote F3
All of these restricted stock units vested on May 13, 2025, one year from the grant date.